Louise Johns

Psychiatry and Mental health · 2001–2014

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Louise Johns trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. van Os
  2. Richie Poulton

Who trusts Louise Johns overall

  1. Charles Fernyhough
  2. J. van Os
  3. R. Linscott
  4. E. Longden
  5. Simon McCarthy-Jones

Papers from Louise Johns's perspective

Ordered by how strongly the researchers Louise Johns trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. (Archives of General Psychiatry)
  2. A cognitive model of the positive symptoms of psychosis (Psychological Medicine)
  3. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. (Archives of General Psychiatry)
  4. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study (British medical journal)
  5. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. (Archives of General Psychiatry)
  6. Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States (Australian and New Zealand journal of psychiatry (Print))
  7. Do we need multiple models of auditory verbal hallucinations? Examining the phenomenological fit of cognitive and neurological models.
  8. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. (Archives of General Psychiatry)
  9. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. (Proceedings of the National Academy of Sciences of the United States of America)
  10. Size of burden of schizophrenia and psychotic disorders. (European Neuropsychopharmacology)

Their papers